These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19327634)

  • 21. Disseminated toxoplasmosis with pulmonary involvement after heart transplantation.
    Fricker-Hidalgo H; Brion JP; Durand M; Chavanon O; Brenier-Pinchart MP; Pelloux H
    Transpl Infect Dis; 2005 Mar; 7(1):38-40. PubMed ID: 15984948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Parahilar lymphadenopathy due to toxoplasmosis].
    Jesiotr M
    Harefuah; 1971 Aug; 81(4):184-5. PubMed ID: 5160520
    [No Abstract]   [Full Text] [Related]  

  • 23. [Contribution on the clinical aspects of acquired toxoplasmosis].
    Bühler F; Denes A
    Schweiz Med Wochenschr; 1968 Nov; 98(44):1739-43. PubMed ID: 5707568
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
    Sedan J
    Mars Med; 1967; 104(4):343-5. PubMed ID: 5621539
    [No Abstract]   [Full Text] [Related]  

  • 25. Recurrent toxoplasmic retinochoroiditis after clindamycin: a case report.
    Murphy GE
    Ann Ophthalmol; 1982 Jul; 14(7):632-3. PubMed ID: 7125453
    [No Abstract]   [Full Text] [Related]  

  • 26. TMP-SMX superior in treating Toxoplasma encephalitis.
    AIDS Patient Care STDS; 1997 Dec; 11(6):459. PubMed ID: 11361876
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drugs used against protozoan infections in man].
    Takada S
    Nihon Rinsho; 1990 Oct; 48(10):2228-33. PubMed ID: 2280469
    [No Abstract]   [Full Text] [Related]  

  • 28. [Limitations of prenatal treatment of congenital toxoplasmosis with a sulfadiazine-pyrimethamine combination].
    Boulot P; Pratlong F; Sarda P; Deschamps F; Hedon B; Laffargue F; Viala JL
    Presse Med; 1990 Mar; 19(12):570. PubMed ID: 2139220
    [No Abstract]   [Full Text] [Related]  

  • 29. Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy.
    Pedrol E; González-Clemente JM; Gatell JM; Mallolas J; Miró JM; Graus F; Alvarez R; Mercader JM; Berenguer J; Jiménez de Anta MT
    AIDS; 1990 Jun; 4(6):511-7. PubMed ID: 2386616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Piringer-Kuchinka lymphadenitis cerviconuchalis: diagnosis and treatment].
    Dvorák R
    Cesk Otolaryngol; 1975 Oct; 24(5):300-4. PubMed ID: 1204073
    [No Abstract]   [Full Text] [Related]  

  • 31. Cervical toxoplasma lymphadenitis: report of a case.
    Siar CH; Foo GC
    Med J Malaysia; 1984 Dec; 39(4):306-10. PubMed ID: 6544939
    [No Abstract]   [Full Text] [Related]  

  • 32. Toxoplasmic polymyositis revisited: case report and review of literature.
    Cuturic M; Hayat GR; Vogler CA; Velasques A
    Neuromuscul Disord; 1997 Sep; 7(6-7):390-6. PubMed ID: 9327404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical aspects, diagnosis and treatment of acquired toxoplasmosis].
    Mathernová V; Catar G
    Med Parazitol (Mosk); 1980; 49(5):27-31. PubMed ID: 7421746
    [No Abstract]   [Full Text] [Related]  

  • 34. Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006.
    Béraud G; Pierre-François S; Foltzer A; Abel S; Liautaud B; Smadja D; Cabié A
    Am J Trop Med Hyg; 2009 Apr; 80(4):583-7. PubMed ID: 19346380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of the treatment on humoral immunity in toxoplasmosis].
    Durquety MC; Verin P; Le Rebeller MJ
    Bull Soc Ophtalmol Fr; 1984 Oct; 84(10):1089-93, 1096. PubMed ID: 6544162
    [No Abstract]   [Full Text] [Related]  

  • 36. [Streptococcus angina, myocarditis and toxoplasmosis following splenectomy].
    Renschler HE; Schumacher K
    Internist (Berl); 1970 Apr; 11(4):150-1. PubMed ID: 4933147
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice.
    McMaster PR; Powers KG; Finerty JF; Lunde MN
    Am J Trop Med Hyg; 1973 Jan; 22(1):14-7. PubMed ID: 4684885
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion.
    Holland GN
    Ophthalmology; 2005 Nov; 112(11):1882-4. PubMed ID: 16271316
    [No Abstract]   [Full Text] [Related]  

  • 39. [Side effects of toxoplasmosis treatment].
    Deroń Z; Jabłkowski M
    Pol Tyg Lek; 1980 Jun; 35(23):857-9. PubMed ID: 6447863
    [No Abstract]   [Full Text] [Related]  

  • 40. Favorable outcome of central nervous system toxoplasmosis occurring in a patient with untreated Hodgkin's disease.
    Green JA; Spruance SL; Cheson BD
    Cancer; 1980 Feb; 45(4):808-10. PubMed ID: 7357497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.